Pathogen recognition receptor crosstalk in respiratory syncytial virus sensing: A host and cell type perspective

Trends in Microbiology

Volumn 21, Issue 11, 2013, Pages 568-574

  Marr, Nico ^a,b   Turvey, Stuart E ^a,b   Grandvaux, Nathalie ^c,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Innate immunity; Pathogen recognition receptors; Pathogenesis; Respiratory syncytial virus

Indexed keywords

BETA INTERFERON; CASPASE RECRUITMENT DOMAIN PROTEIN 15; MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 5; MYELOID DIFFERENTIATION FACTOR 88; PALIVIZUMAB; PATTERN RECOGNITION RECEPTOR; PHOSPHORYL LIPID A; PROTEIN KINASE R; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; UNCLASSIFIED DRUG;

CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; DENDRITIC CELL; EPITHELIUM CELL; HUMAN; IMMUNE EVASION; IMMUNOLOGICAL MEMORY; INNATE IMMUNITY; INTERFERON INDUCTION; NONHUMAN; PRIORITY JOURNAL; REINFECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; VIRUS ENTRY; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

INNATE IMMUNITY; PATHOGEN RECOGNITION RECEPTORS; PATHOGENESIS; RESPIRATORY SYNCYTIAL VIRUS;

HUMANS; IMMUNITY, INNATE; RECEPTORS, PATTERN RECOGNITION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 84887017357     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2013.08.006     Document Type: Review

References (60)

1. Collins P.L., Melero J.A. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res. 2011, 162:80-99.
2. Takeuchi O., Akira S. Innate immunity to virus infection. Immunol. Rev. 2009, 227:75-86.
3. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
4. Kurt-Jones E.A., et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 2000, 1:398-401.
5. Murawski M.R., et al. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J. Virol. 2009, 83:1492-1500.
6. Delgado M.F., et al. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat. Med. 2009, 15:34-41.
7. Marr N., Turvey S.E. Role of human TLR4 in respiratory syncytial virus-induced NF-kappaB activation, viral entry and replication. Innate Immun. 2012, 18:856-865.
8. Dakhama A., et al. Permissiveness of guinea pig alveolar macrophage subpopulations to acute respiratory syncytial virus infection in vitro. Chest 1998, 114:1681-1688.
9. Rivera-Toledo E., Gomez B. Respiratory syncytial virus persistence in macrophages alters the profile of cellular gene expression. Viruses 2012, 4:3270-3280.
10. Johnson T.R., et al. Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus. PLoS ONE 2011, 6:e16458.
11. Guerrero-Plata A., et al. Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am. J. Respir. Cell Mol. Biol. 2006, 34:320-329.
12. Liu P., et al. Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J. Virol. 2007, 81:1401-1411.
13. Yoboua F., et al. Respiratory syncytial virus-mediated NF-kappa B p65 phosphorylation at serine 536 is dependent on RIG-I, TRAF6, and IKK beta. J. Virol. 2010, 84:7267-7277.
14. Liu P., et al. Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-kappaB2 complexes via a novel retinoic acid-inducible gene-I:NF-kappaB-inducing kinase signaling pathway. J. Biol. Chem. 2008, 283:23169-23178.
15. Lee H.C., et al. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J. Allergy Clin. Immunol. 2012, 130:1187-1196.
16. Okabayashi T., et al. Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Virus Res. 2011, 160:360-366.
17. Lifland A.W., et al. Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J. Virol. 2012, 86:8245-8258.
18. Baum A., et al. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:16303-16308.
19. Loo Y.M., Gale M. Immune signaling by RIG-I-like receptors. Immunity 2011, 34:680-692.
20. Demoor T., et al. IPS-1 signaling has a nonredundant role in mediating antiviral responses and the clearance of respiratory syncytial virus. J. Immunol. 2012, 189:5942-5953.
21. Sabbah A., et al. Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 2009, 10:1073-1080.
22. Munir M., Berg M. The multiple faces of protein kinase R in antiviral defense. Virulence 2013, 4:85-89.
23. Groskreutz D.J., et al. Respiratory syncytial virus limits alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha) phosphorylation to maintain translation and viral replication. J. Biol. Chem. 2010, 285:24023-24031.
24. Ioannidis I., et al. Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells. J. Virol. 2013, 87:3261-3270.
25. Rudd B.D., et al. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J. Virol. 2005, 79:3350-3357.
26. Shirey K.A., et al. Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent. Mucosal Immunol. 2010, 3:291-300.
27. Rallabhandi P., et al. Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2. MBio 2012, 3. e00218-12.
28. Haynes L.M., et al. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol. 2001, 75:10730-10737.
29. Ehl S., et al. The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur. J. Immunol. 2004, 34:1146-1153.
30. Lukacs N.W., et al. Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation. J. Immunol. 2010, 185:2231-2239.
31. Hornung V., et al. Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virus. J. Immunol. 2004, 173:5935-5943.
32. Kato H., et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005, 23:19-28.
33. Gilliet M., et al. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 2008, 8:594-606.
34. Kim T., et al. Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:15181-15186.
35. Barton G.M., Kagan J.C. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat. Rev. Immunol. 2009, 9:535-542.
36. Tayyari F., et al. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat. Med. 2011, 17:1132-1135.
37. Allen K.L., et al. A novel pathway for human endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood 2012, 119:884-893.
38. San-Juan-Vergara H., et al. Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells. J. Virol. 2012, 86:1832-1843.
39. Krzyzaniak M.A., et al. Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein. PLoS Pathog. 2013, 9:e1003309.
40. Mercer J., Greber U.F. Virus interactions with endocytic pathways in macrophages and dendritic cells. Trends Microbiol. 2013, 21:380-388.
41. Morris S., et al. Autophagy-mediated dendritic cell activation is essential for innate cytokine production and APC function with respiratory syncytial virus responses. J. Immunol. 2011, 187:3953-3961.
42. Ariffin J.K., Sweet M.J. Differences in the repertoire, regulation and function of Toll-like Receptors and inflammasome-forming Nod-like Receptors between human and mouse. Curr. Opin. Microbiol. 2013, 16:303-310.
43. Klein Klouwenberg P., et al. The role of Toll-like receptors in regulating the immune response against respiratory syncytial virus. Crit. Rev. Immunol. 2009, 29:531-550.
44. Paulus S.C., et al. Common human Toll-like receptor 4 polymorphisms - role in susceptibility to respiratory syncytial virus infection and functional immunological relevance. Clin. Immunol. 2007, 123:252-257.
45. Awomoyi A.A., et al. Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J. Immunol. 2007, 179:3171-3177.
46. Tal G., et al. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J. Infect. Dis. 2004, 189:2057-2063.
47. von Bernuth H., et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 2008, 321:691-696.
48. Kollmann T.R., et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J. Immunol. 2009, 183:7150-7160.
49. Villenave R., et al. In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:5040-5045.
50. Fonceca A.M., et al. Primary airway epithelial cultures from children are highly permissive to respiratory syncytial virus infection. Thorax 2012, 67:42-48.
51. Aarbiou J., et al. Lentiviral small hairpin RNA delivery reduces apical sodium channel activity in differentiated human airway epithelial cells. J. Gene Med. 2012, 14:733-745.
52. Pollard A.J., et al. Human microbial challenge: the ultimate animal model. Lancet Infect. Dis. 2012, 12:903-905.
53. Querec T.D., Pulendran B. Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever Vaccine 17D. Adv. Exp. Med. Biol. 2007, 590:43-53.
54. Prince G.A., et al. Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease. Vaccine 2001, 19:2048-2054.
55. Boukhvalova M.S., et al. The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease. Vaccine 2006, 24:5027-5035.
56. Villenave R., et al. Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells. Virol. J. 2011, 8:43. 10.1186/1743-422X-8-43.
57. Stokes K.L., et al. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. J. Virol. 2011, 85:5782-5793.
58. Kwilas S., et al. Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans. J. Virol. 2009, 83:10710-10718.
59. Collins C.H., Kennedy D.A. Laboratory-Acquired Infection: History, Incidence, Causes and Preventions 1999, 38-53. Chapter 2, Exposure, sources and route of infection, Butterworth-Heinemann. 4th edn.
60. Bem R.A., et al. Animal models of human respiratory syncytial virus disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 301:L148-L156.